Dr. Lauralyn McIntyre is an Intensivist and Critical Care Research Chair at the Ottawa Hospital, an Associate Professor in the Department of Medicine with a Cross Appointment to the Department of Epidemiology and Community Medicine at the University of Ottawa, and a Senior Scientist with the Ottawa Hospital Research Institute. She has served on the executive of the Canadian Critical Care Trials Group (CCCTG), is a member of the Translational Biology Group (CCCTBG), Co-Chair of the grants and manuscripts committee for Sepsis Canada and was a panel member (2106) and panel Co-Chair (2021) for the Surviving Sepsis Guidelines.

Lauralyn has published 225 peer-review articles and has mentored many undergraduate students and postgraduate trainees throughout her career. Her peer-reviewed funded research programs span from highly experimental and translational to usual care research questions that are multi-method and multi-disciplinary and focus on randomized trials related to fluid resuscitation and transfusion of stem cells in the acutely ill and septic shock. Throughout her career, Dr. McIntyre has collaborated locally and nationally with CCCTG and CCCTBG researchers across 33 adult and pediatric research programs.

Monica Taljaard is a Senior Scientist in the Methodological and Implementation Research Program at the Ottawa Hospital Research Institute (OHRI) and Full Professor in the School of Epidemiology and Public Health at the University of Ottawa. Her main research interests are in the design, analysis and ethics of pragmatic and cluster randomized trials. As a methodologist with the Ottawa Methods Centre, she works with clinicians and researchers from a variety of backgrounds in the design and analysis of their studies including clinical trials and observational studies. She has published over 500 peer reviewed journal articles and helped secure >$190 million in peer-reviewed research grants, including >$60M as principal or co-principal investigator. She is Deputy Editor of Clinical Trials: Journal of the Society for Clinical Trials.

Dr. Fabrizio Monaco, MD is currently Head of Cardio-Thoracic and Vascular Anesthesia at IRCCS San Raffaele Scientific Institute and Assistant Professor (Clinical) in Anesthesiology. His main research and academic interests are perioperative medicine, cardio-thoracic anesthesia and intensive care, mechanical circulatory support and anesthetic pharmacology. He also serves as Co-Chair of the EACTAIC Sub-Committee on Cardiopulmonary Bypass, ECMO and Mechanical Circulatory Support.

Twitter:  @md_monaco

Ewan Goligher MD, PhD is Associate Professor of Medicine and Physiology in the Interdepartmental Division of Critical Care Medicine at the University of Toronto and a Senior Scientist at the Toronto General Hospital Research Institute. 

His clinical and translational research program focuses on the mechanisms and impact of lung and diaphragm injury during mechanical ventilation and extracorporeal life support. He serves as co-chair of the PRACTICAL international adaptive platform trial testing a range of novel interventions for  acute hypoxemic respiratory failure.

Michaël Chassé is a medical specialist in intensive care at the Centre hospitalier de l'Université de Montréal (CHUM), a principal scientist at the CHUM Research Centre and an associate professor in the Department of Medicine and the School of Public Health at the Université de Montréal. He also holds a PhD in Epidemiology from the University of Ottawa. He is Associate Scientific Director of Data Science at the CHUM Research Centre and the Scientific Director of the CHUM Centre for The Integration and Analysis of Medical Data (CITADEL) which brings together a scientists and professionals specialized in health data science, biostatistics, bioinformatics and machine learning.

His main research interests focus on improving traditional methods of epidemiological research using new technologies such as machine learning and innovative clinical trials, particularly in areas related to intensive care such as organ donation and death determination, organ transplantation and blood transfusions.

Twitter: @Michael_Chasse

Dr Jai Shankar is a diagnostic and interventional Neuroradiologist in Winnipeg, Canada. He is Professor and Associate Head of Research and Academics, Department of Radiology, University of Manitoba, Winnipeg, Canada. His research focuses on perfusion imaging in stroke and critically ill patients as well as in several interventional neuroradiology fields.

He leads several cohort studies on the role of CT perfusion in patients in ICU, severe traumatic brain injury and comatose cardiac arrest patients. He leads the randomized control trial on Embolization of middle meningeal artery (EMMA) for Subdural Hematoma (EMMA Can)

Dr. Taylor is the J. Griswold and Margery Hopkins Ruth Research Professor of Medicine and the Chief of Hospital Medicine at the University of Michigan. Her research focuses on using rigorous methods to develop and test complex health interventions to improve outcomes for hospitalized patients.

She leads multiple pragmatic trials and is known for her work on both early treatment of sepsis and optimizing recovery practices for sepsis survivors.

Twitter:  @StephptaylorCLT

Dr. Marion Moseby-Knappe is a Consultant Neurologist at the Department of Neurorehabilitation at Skåne University Hospital in Lund, Sweden. She holds a PhD within neurological prognostication after cardiac arrest from Lund University. Her main research interest is understanding brain injury and optimizing the prediction of outcome after cardiac arrest. Together with the team at Lund University Centre for Cardiac Arrest, she has published prognostic studies on brain injury biomarkers, neuroimaging, neurophysiology and neurological prognostication within the TTM1 and TTM2 trials.

Marion is responsible for the neurological prognostication within the international multicentre STEPCARE trial, and principal investigator of the EARLY-NEURO substudy combining biomarkers, computed tomography and electroencephalography for early neuroprognostication.

Niklas Nielsen is professor of anesthesiology and intensive care at Lund University, Sweden and vice dean of the Medical Faculty. He has during the last two decades been leading large international cardiac arrest studies and trials building a network of over 80 hospitals in 18 countries focusing on targeted temperature management for ischemic brain damage and prognostication of outcome. 

The trials, TTM1 and TTM2, have had considerable impact on clinical guidelines worldwide for post cardiac arrest care, neuroprognostication and follow-up. He is now chief investigator for the STEPCARE project, a randomizied trial with 3500 participants looking into fever management, sedation strategies and level of mean arterial pressure after cardiac arrest.

He would love to sail to the Critical Care Reviews Belfast meeting.

Clinical Professor Litton is an Intensive Care Specialist and Director of ICU research at Fiona Stanley Hospital, Perth, Western Australia. He is a NHMRC Research Fellow who leads research programs in optimising recovery after ICU, diagnosing and treating sepsis, gut microbiome changes of critical illness microbiome, and improving ICU sleep. He is the Clinical Director of the Australia and New Zealand Intensive Care Society (ANZICS) Critical Care Resources Registry that monitors ICU resourcing to improve safety and quality. Prof Litton has received over $12M AUD in competitive grant funding as Chief Investigator and has published more than 150 manuscripts in the peer review literature.

Andrew Klein is a Consultant at Royal Papworth Hospital Deparment of Anaesthesia and Intensive Care. He is the former Editor-in-Chief of the journal Anaesthesia and the Vice-President of the Association of Anaesthetist.

Andrew’s main research interests are improving outcomes after major surgery and iron/B12 deficiency and anaemia. Andrew is a keen cricket supporter and lifelong and long-suffering West Ham fan.

Paul is Co-Director, and Clinical Trials Unit Director, at the Intensive Care National Audit & Research Centre (ICNARC) . Paul is an epidemiologist with over 20 years’ experience of conducting multicentre randomised clinical trials, initially in Cancer, but at ICNARC focussed in adult and paediatric critical care. Paul is the Joint-Chief Investigator for the UK-ROX trial - a highly challenging trial within the critical care setting, using extensive data collected routinely by the national clinical audit for critical care (Case Mix Programme) database.

Paul led the development of the NIHR-funded PIVOTAL adaptive platform trial evaluating multiple interventions in paediatric critical care and sits on the REMAP-CAP International Trial Steering Committee. He sits on both the NIHR Critical Care National Specialty Group, which has responsibility for overseeing delivery of studies on the NIHR portfolio for critical care, and the UK Critical Care Research Group.

Twitter:  @PaulMouncey

Daniel is Professor of Perioperative and Intensive Care Medicine at the University of Plymouth and a consultant in intensive care medicine at Derriford Hospital in Plymouth. He has a PhD in applied physiology from University College London and his main research interest is focused on the physiology and clinical implications of too much or too little oxygen. He has been involved in several research expeditions to high altitude and in 2007 summited Mount Everest with the Xtreme Everest team; an blood gas taken from him near the summit showed one of the lowest arterial oxygenation readings ever recorded in a human. Daniel is a chief investigator for the UK-ROX trial evaluating conservative oxygen therapy in mechanically ventilated patients and the EXAKT sub-study to assess the accuracy of pulse oximeters in patients with different skin tones. He is the editor in chief of the Journal of the Intensive Care Society and in 2016 was awarded Officer of the Order of the British Empire (OBE), for services to the prevention of infectious diseases.

Kathryn Maitland is Professor of Paediatrics at Imperial College, London and is based full-time in East Africa, where she leads a research group whose portfolio includes severe malaria, bacterial sepsis and severe malnutrition in children. Her team conducted the largest trial in critically children ever undertaken in Africa (FEAST trial) examining fluid resuscitation strategies in children with severe febrile illness, showing that fluid boluses increased mortality. She has also lead the landmark TRACT trial, investigating transfusion and other treatment strategies in 3800 African children severe life-threatening anaemia, and the COAST trial (Children Oxygenation Administration Strategies Trial) examining the optimum oxygen saturation threshold for which oxygen should be targeted and how best to administer oxygen, by high flow or low flow, in 4200 severely ill African children. In recognition of her contribution to medical research and healthcare she was recently elected to Fellowship of the Academy of Medical Sciences.

Twitter:  @KathMaitland

Dr. Elizabeth George is a statistician and researcher with 15 years of experience working on clinical trials focused on acutely ill children presenting to hospitals in Africa. She has contributed to award-winning large trials that have challenged the status quo, led to changes in guidelines, and provided crucial evidence supporting existing guidelines. These trials have sparked numerous global debates and discussions. Her work has included trials on fluid resuscitation for pediatric shock, blood transfusion volumes for severe anemia, antibiotics for severe malaria and bacterial co-infection, and fluids for children with gastroenteritis with or without severe malnutrition.

Dr. George leads subsequent analyses, publications, and dissemination projects from these trials, developing analysis plans and collaborating closely with colleagues. She has also served as a trial statistician for smaller trials that have clarified underlying mechanisms and helped inform future research.

Dr. George is passionate about conducting high-quality clinical trials to answer critical questions and provide evidence for treatment guidelines for children presenting to hospitals in Africa.

Twitter:  @lcgeorge13

Lee-anne Chapple is the Senior Critical Care Dietitian at the Royal Adelaide Hospital, and Associate Professor at the University of Adelaide in Australia. She leads the intensive care nutrition research program at the Royal Adelaide Hospital, focusing on protein delivery and utilisation, post-ICU nutrition, and recovery.

A/Prof Chapple has collaborated on more than 90 research publications and received more than $10 million Australian dollars in research funding. She was the post-doctoral research fellow and co-Project Manager for the TARGET Protein trial. 

Twitter:  @LSChapple

Matt is a Research Dietitian at the Royal Adelaide Hospital and PhD candidate at University of Adelaide. Matt has worked within the Intensive Care Unit Research Department at the Royal Adelaide Hospital for over 15 year and most recently co-project managed the TARGET Protein Trial.

Matt commenced his PhD in July 2022 and is anticipated to complete this by the end of 2025. The focus of Matt’s doctoral research is to evaluate enteral protein delivery and protein metabolism in the critically ill.

Twitter:  @msummo2

Once he appreciated that being both scared of short pitched bowling and having a weakness against the swinging ball outside off-stump were major impediments to his dream of batting first drop for the Australian cricket team, Adam transitioned his career aspirations to medicine.

He currently pays the mortgage with employment as Staff Specialist, Head of Intensive Care Unit Research, and Deputy Director Intensive Care Unit at The Royal Melbourne Hospital. His academic appointments include Professorial Fellow in Intensive Care and Deputy Director of the Department of Critical Care Medicine at the University of Melbourne. From an earlier age, Adam developed a passion for frozen milk-based foods that stimulate sweet taste receptors. He continues to enjoy
following this passion whenever possible.

Twitter:  @MelbourneICU

Jo McPeake is Professor of Nursing at the University of Cambridge and Cambridge University Hospital’s NHS Foundation Trust. With a background in acute and critical care nursing, Professor McPeake leads a programme of research dedicated to improving the outcomes of critically ill patients and their family members. Her programme of research has a particular focus on how social inequalities influence healthcare access and outcomes. Characteristically using mixed methods approaches, Professor McPeake has experience of evaluating complex healthcare interventions in the acute care environment.

Zudin Puthucheary is a Professor of Intensive Care Medicine at the William Harvey Institute, Queen Mary, University of London, and a Consultant at the Royal London Hospital Adult Intensive Care Unit. He graduated from Nottingham University in 1997, and moved to London post MRCP in 2000. Following a 3-year stint in Sydney, he started his Respiratory training in Bristol, before completing his critical care training in London.

Zudin's research focusses on acquired functional disability and skeletal muscle physiology, and specifically the use of metabolic and exercise interventions to prevent and treat acute muscle wasting. He is a nationally elected Council member of the Intensive Care Society (UK) and was the inaugural chair of the UK National Post-Intensive Care Rehabilitation Collaborative, a multi-professional cross-disciplinary group focussing on rehabilitation and restitution of critical illness survivors. He is the Chief Investigator of the ASICS-II and ASICS-TBI trials, investigating the efficacy of ketogenic feeding in preventing muscle wasting and secondary brain injury.

Kenny Baillie is Professor of Experimental Medicine at the University of Edinburgh and Consultant in Intensive Care Medicine.

He graduated from the University of Edinburgh with a BSc(Hons) in Physiology in 1999 and MBChB in 2002. He completed basic training in medicine in Glasgow, and in anesthesia in Edinburgh. During this time he led a series of high altitude research projects in Bolivia, and founded a high-altitude research charity, Apex. He was appointed as a clinical lecturer on the ECAT (Edinburgh Clinical Academic Track) at the University of Edinburgh in 2008, and completed a Wellcome Trust-funded PhD in statistical genetics in 2012. He was awarded a Wellcome-Beit Prize Intermediate Clinical Fellowship in 2013. He led a global consensus on harmonisation of research studies in outbreaks for the International Severe Acute Respiratory Infection Consortium (ISARIC), and worked with WHO on H1N1 influenza, MERS, and Ebola. After completing clinical training in 2014 he worked as a visiting scientist at the Broad Institute of Harvard and MIT, before returning to the Roslin Institute, University of Edinburgh to establish a research program in translational applications of genomics in critical care medicine. He works as a consultant in the intensive care unit at the Royal Infirmary, Edinburgh. During the Covid outbreak in 2020-21, he led the UK-wide GenOMICC and ISARIC4C studies, and contributed to the design and delivery of the RECOVERY trial. He discovered new biological mechanisms underlying critical illness in Covid, and contributed to the discovery of effective drug treatments to reduce mortality.

He leads a research programme in translational genomics - using genetic signals from critically ill patients to identify both the targets for drug therapy, and the groups of patients likely to benefit most from any treatment, and testing those therapeutic ideas in highly-efficient model systems.

Prof. Niall Ferguson is Professor in the Interdepartmental Division of Critical Care Medicine, Department of Medicine, at the University of Toronto, with cross-appointments in the Department of Physiology and the Institute of Health Policy, Management and Evaluation.  He is a practicing Intensivist and Clinician-Scientist at the University Health Network and is the Medical Director of the Toronto General Hospital Medical-Surgical ICU. He is a Senior Scientist in the Toronto General Research Institute and Director of the Toronto General Hospital Clinical Research Unit.

At a provincial level, Dr. Ferguson is Deputy chair of the Ontario Critical Care Command Centre.  Dr. Ferguson’s research, which is supported by national and international peer-reviewed grants, investigates treatments for patients with acute hypoxemic respiratory failure with a focus on clinical trials in mechanical ventilation and extra-corporeal life support.  He has published more than 300 papers listed on PubMed and his H-index is over 90.  Dr. Ferguson is the Chair for Critical Care Canada Forum, Canada’s national critical care conference. He is a frequent invited speaker at national and international meetings, having given over 400 such talks.

Darren Taichman, MD, PhD, MACP is a pulmonary and critical care physician who practices and teaches at the University of Pennsylvania.  At Penn, he was Director of the intensive care unit and led research programs focused on critical care medicine and pulmonary vascular disease.  Dr. Taichman’s editorial work began in 2007 at the Annals of Internal Medicine, where he was the Executive Editor as well as Vice President of the American College of Physicians, the largest medical specialty organization in the United States.  He served as Secretary of the International Committee of Medical Journal Editors from 2014 – 2021.  In 2020, Dr. Taichman was appointed Deputy Editor and Online Editor of the New England Journal of Medicine, as well as the Executive Strategy Editor for the NEJM Group.  He continues to teach and see patients at the University of Pennsylvania, with a specific focus on the treatment of pulmonary hypertension.